Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:33 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | Soleus Private Equity Fund III L.P. | 3,994,629 8.700% | 3,994,629 (New Position) | Filing History |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Soleus Private Equity Fund III L.P. | 1,343,665 9.000% | 1,343,665 (New Position) | Filing History |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | CalciMedica, Inc. CALC | Soleus Private Equity Fund III L.P. | 1,175,856 8.500% | 1,175,856 (New Position) | Filing History |
| 2024-11-14 3:30 pm Sale | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III L.P. | 4,234,765 0.500% | -44,652,330 (-91.34%) | Filing History |
| 2024-10-28 4:00 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | Soleus Private Equity Fund III L.P. | 7,228,908 9.990% | 7,228,908 (New Position) | Filing History |
| 2024-02-06 4:15 pm Purchase | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III L.P. | 48,887,095 7.000% | 500,000 (+1.03%) | Filing History |
| 2024-02-06 4:15 pm Sale | 2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | Soleus Private Equity Fund III L.P. | 1,820,365 9.990% | -47,690 (-2.55%) | Filing History |
| 2024-01-10 09:00 am Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | Soleus Private Equity Fund III L.P. | 7,293,007 8.100% | 7,293,007 (New Position) | Filing History |
| 2023-10-26 5:00 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | Soleus Private Equity Fund III L.P. | 1,868,055 9.990% | 1,868,055 (New Position) | Filing History |
| 2023-07-26 4:31 pm Purchase | 2023-07-24 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III L.P. | 48,387,095 7.500% | 48,387,095 (New Position) | Filing History |
| 2023-05-24 4:31 pm Purchase | 2023-05-16 | 13G | InspireMD, Inc. NSPR | Soleus Private Equity Fund III L.P. | 2,199,118 9.900% | 2,199,118 (New Position) | Filing History |